go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Alaska rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $4,365 · 10th–90th $4,365$6,1660%20%40%90th$4,365Professionalmedian $6,026 · 10th–90th $3,715$6,0260%20%40%10th$6,026$100.0$200.0$500.0$1.0K$2.0K$5.0K$10.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$4,265.80
Median
$4,365.16
Typical High
$6,025.60
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
Moda Health
Setting
Facility
Modifier
Global
Typical Low
$4,365.16
Median
$4,365.16
Typical High
$6,165.95
Moda Health
Setting
Professional
Modifier
Global
Typical Low
$60.26
Median
$60.26
Typical High
$5,248.07
Premera BCBS
Setting
Professional
Modifier
Global
Typical Low
$6,025.60
Median
$6,025.60
Typical High
$6,025.60
Providence
Setting
Facility
Modifier
Global
Typical Low
$4,365.16
Median
$4,365.16
Typical High
$6,165.95
Providence
Setting
Professional
Modifier
Global
Typical Low
$60.26
Median
$3,548.13
Typical High
$5,248.07
United
Setting
Professional
Modifier
Global
Typical Low
$4,168.69
Median
$6,309.57
Typical High
$11,748.98